Evidence map›Paper›PMID 32118512›Full record

ArticleHuman vaccines & immunotherapeutics2020

Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks.

Wei Qin, Xiao-Kang Xu, Yao Wang, Xiang-Mei Meng, Cheng-Wu Yang, Feng Xia, Hong Su

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wei QinDepartment of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention , Lu'an, Anhui, China.ORCID 0000-0002-8961-4425
Xiao-Kang XuDepartment of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention , Lu'an, Anhui, China.
Yao WangDepartment of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention , Lu'an, Anhui, China.
Xiang-Mei MengDepartment of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention , Lu'an, Anhui, China.
Cheng-Wu YangDepartment of Expanded Program on Immunization, Huoshan County Center for Disease Control and Prevention , Lu'an, Anhui, China.
Feng XiaDepartment of Expanded Program on Immunization, Huoqiu County Center for Disease Control and Prevention , Lu'an, Anhui, China.
Hong SuDepartment of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University , Hefei, Anhui, China.
Anhui Medical University · CNAnhui Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough a varicella vaccine has been available in China since 1998 in the private sector, varicella outbreaks and breakthrough varicella (BV) still occur. In 2018, four varicella outbreaks with high BV rate sequentially occurred in four schools in Lu'an, sparking local public health authority's concerns on the varicella vaccine. Therefore, we conducted this investigation to evaluate varicella vaccine effectiveness (VE), characterize BV, and detect potential risk factors associated with BV.

methodsThis was a three-stage study. First, a retrospective cohort study was done in each school to estimate the VEs of varicella vaccine  during outbreaks. Second, a descriptive epidemiological method was used to describe the characteristics of the four outbreaks and to compare the clinical characteristics between the BV cases and unvaccinated varicella cases. To identify the risk factors associated with BV, we conducted an unmatched case-control study in the third stage of the study.

resultsA total of 199 cases were identified among four outbreaks, and the overall attack rate was 14%. Of 1203 students with available vaccination information, 822 (68%) were vaccinated at least once. The overall VEs among four outbreaks ranged from 19% to 69%, whereas the VE against moderate or severe varicella ranged from 74% to 90%. Compared with unvaccinated varicella cases, the moderate or severe varicella (

conclusionsThe overall VE was insufficient to protect varicella infection, and the VE for moderate or severe varicella was only moderate. The manifestations of BV cases were generally milder than those seen in natural varicella infection. The time since vaccination and the intensity of exposure are risk factors for developing BV during an outbreak.

Indexed as

ChickenpoxCase-Control StudiesChickenpox VaccineChildChinaDisease OutbreaksHumansRetrospective StudiesRisk FactorsVaccinationChickenpox VaccineBreakthrough varicellaRisk factorVaccine effectivenessVaricella

Identifiers

PMID32118512
PMCPMC7482709
OpenAlexW3008999542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.